Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2025-12-25 @ 7:24 PM
Study NCT ID:
NCT07054632
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-10
First Post:
2025-06-27
Is Possible Gene Therapy:
True
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of LX101 for Inherited Retinal Dystrophy Associated With RPE65 Mutations
Sponsor:
Innostellar Biotherapeutics Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-13
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-08
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-27
First Submit QC Date:
None
Study First Post Date:
2025-07-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-07
Last Update Post Date:
2025-07-10
Last Update Post Date Type:
ACTUAL